AIGH Capital Management LLC trimmed its position in Biodesix, Inc. (NASDAQ:BDSX – Free Report) by 5.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,658,946 shares of the company’s stock after selling 247,752 shares during the quarter. Biodesix comprises approximately 3.4% of […]
Capital One Financial initiated coverage on shares of Immutep (NASDAQ:IMMP – Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. The brokerage issued an overweight rating and a $10.00 target price on the biotechnology company’s stock. Immutep Stock Up 4.7 % Immutep stock opened at $3.10 on Friday. The firm’s 50-day […]
Capital One Financial began coverage on shares of Immutep (NASDAQ:IMMP – Free Report) in a research note released on Friday, Marketbeat reports. The brokerage issued an overweight rating and a $10.00 price target on the biotechnology company’s stock. Immutep Stock Performance NASDAQ IMMP opened at $3.10 on Friday. Immutep has a 1 year low of […]
TD Cowen started coverage on shares of Biodesix (NASDAQ:BDSX – Free Report) in a research report sent to investors on Monday, MarketBeat reports. The firm issued a buy rating and a $2.80 price objective on the stock. A number of other brokerages have also recently issued reports on BDSX. Lake Street Capital began coverage on […]
Lake Street Capital assumed coverage on shares of Biodesix (NASDAQ:BDSX – Free Report) in a report issued on Friday, Marketbeat reports. The brokerage issued a buy rating and a $3.00 price target on the stock. Separately, Canaccord Genuity Group reaffirmed a buy rating and set a $3.50 target price on shares of Biodesix in a […]